Acute Effect of the V2 Receptor Blocker, Tolvaptan, on Dyspnea in Patients Hospitalized with Heart Failure: Results of the SECRET of CHF

Marvin A. Konstam; Michael Kiernan; Arthur Chandler; Ravi Dhingra; Freny Mody; Howard Eisen; W. Herbert Haught; Lynne Wagoner; Divya Gupta; Richard Patten; Paul Gordon; Kenneth Korr; Russell Fileccia; Douglas Gregory; Patricia Wedge; Matthew Romeling; Jeremy M. Konstam; James E. Udelson; SECRET of CHF Investigators Coordinators and Committee Members

doi:10.1016/j.cardfail.2016.09.009

Back

Acute Effect of the V2 Receptor Blocker, Tolvaptan, on Dyspnea in Patients Hospitalized with Heart Failure: Results of the SECRET of CHF

Journal article

Open access

Peer reviewed

Acute Effect of the V2 Receptor Blocker, Tolvaptan, on Dyspnea in Patients Hospitalized with Heart Failure: Results of the SECRET of CHF

Marvin A. Konstam, Michael Kiernan, Arthur Chandler, Ravi Dhingra, Freny Mody, Howard Eisen, W. Herbert Haught, Lynne Wagoner, Divya Gupta, Richard Patten, …

Journal of cardiac failure, v 22(11), pp 939-939

Nov 2016

DOI: https://doi.org/10.1016/j.cardfail.2016.09.009

Featured in Collection : UN Sustainable Development Goals @ Drexel

Files and links (1)

url

https://doi.org/10.1089/aid.2015.0336View

Published, Version of Record (VoR)Open Access (License Unspecified), Open

Metrics

22 Record Views

2 citations in Web of Science

Details

Title: Acute Effect of the V2 Receptor Blocker, Tolvaptan, on Dyspnea in Patients Hospitalized with Heart Failure: Results of the SECRET of CHF
Creators: Marvin A. Konstam - Tufts Medical Center
Michael Kiernan - Tufts Medical Center
Arthur Chandler - University Cardiology Associates, Augusta, GA
Ravi Dhingra - University of Wisconsin–Madison
Freny Mody - VA Greater Los Angeles Healthcare System
Howard Eisen - Drexel University
W. Herbert Haught - Heart Center Research, Huntsville, AL
Lynne Wagoner - Mercy Hospital, Fairfield, OH
Divya Gupta - Emory University
Richard Patten - Lahey Medical Center
Paul Gordon - Miriam Hospital
Kenneth Korr - Miriam Hospital
Russell Fileccia - The Ark
Douglas Gregory - Cardiovascular Clinical Science Foundation
Patricia Wedge - Cardiovascular Clinical Science Foundation
Matthew Romeling - Cardiovascular Clinical Science Foundation
Jeremy M. Konstam - Cardiovascular Clinical Science Foundation
James E. Udelson - Tufts Medical Center
SECRET of CHF Investigators Coordinators and Committee Members
Publication Details: Journal of cardiac failure, v 22(11), pp 939-939
Publisher: Elsevier
Resource Type: Journal article
Language: English
Web of Science ID: WOS:000388059200020
Other Identifier: 991019335244104721

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Domestic collaboration
Web of Science research areas: Cardiac & Cardiovascular Systems

Acute Effect of the V2 Receptor Blocker, Tolvaptan, on Dyspnea in Patients Hospitalized with Heart Failure: Results of the SECRET of CHF

Files and links (1)

Metrics

Details

UN Sustainable Development Goals (SDGs)

InCites Highlights

Drexel University Social media